FDA asks drugmaker Eli Lilly for more safety information on its new GLP-1 weight loss pill
The Independent | Latest news and features from US, UK and worl…
April 16, 2026
At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be linked to liver, heart and gastrointestinal problems
Discussion in the ATmosphere